Preprint
Article

This version is not peer-reviewed.

In Vitro Antibacterial Evaluation of Leaf Extracts of Medicinal Plants in the Treatment of Escherichia coli, Klebsiella pneumoniae, and Salmonella Calve Diarrhea

Submitted:

04 August 2025

Posted:

05 August 2025

You are already at the latest version

Abstract
This study employed the disc diffusion and broth microdilution tests to evaluate the antibacterial activities of the methanolic leaf extract of five medicinal plants (Vernonia amygdalina, Cordia africana, Calpurnia aurea, Croton macrostachyus, and Melia azedarach) against Salmonella, Escherichia coli, and Klebsiella pneumoniae. The extracts of Calpurnia aurea, Melia azedarach, and Vernonia amygdaline showed comparable effects (P > 0.05) with gentamicin. The isolates and laboratory strains were most susceptible to the original concentration (1000 mg/ml) of Vernonia amygdaline on Salmonella (19.33 to 20.00 mm) and E. coli (21.33 mm). Vernonia amygdaline (1000 mg/ml) showed significantly (P < 0.05) superior activity on clinical isolates of Salmonella and E. coli. At 1000 mg/ml, Melia azedarach had significant (P < 0.05) superiority over other plants against K. pneumoniae. The minimum inhibitory concentration (MIC) ranged from 6.09 mg/ml (E. coli) to 48.75 mg/ml (Salmonella), and the minimum bactericidal concentration (MBC) value ranged from 12.18 mg/ml (E. coli) to 97.5 mg/ml (Salmonella). Calpurnia aurea and Vernonia amygdalina had all the tested secondary metabolites, except for cardiac glycosides. The yield percentage ranged from 7.9 % (C. macrostachyus) to 11.9 % (Calpurnia aurea and Cordia africana). These results support the potential of plant-based extracts as alternative antimicrobial agents.
Keywords: 
;  ;  ;  ;  ;  

1. Introduction

Antibacterial treatment is utilized broadly in animal medicine to treat bacterial infections, including calf loose bowels, with the main target being coliforms and Salmonella [1, 2, 3). The unpredictable utilization of antibacterial is related to the development of antibacterial resistance, particularly in gram-negative bacteria [4]. Particularly, the treatment of emerging strains of bacteria causing diarrhea in calves has become difficult due to their increased resistance to available antibiotics [5,6,7,8,9]. The development of antibacterial resistance among pathogens is not only a developing concern in veterinary pharmaceuticals, but also to people [10]. Thus, sometimes, a large proportion (up to 60 %) of isolates shared between diarrheic calves and contact children exhibited multidrug resistance to commonly used medications [11].
Gram-negative bacteria in the Enterobacteriaceae are significant inhabitants of the animal gut and are closely related to antibiotic resistance. Concerning expanding antibacterial resistance, lowering antibiotics in food-producing animals focuses on alternative and preventive medications. From these, phytotherapy can be used as an alternative to antibiotics in gastroenteric pathogens [12,13]. Compared to chemically synthesized mono-target drugs, the multicomponent composition of medicinal plants offers a special advantage, such as synergistic or added substance impacts within the living being [14,15].
For centuries, medicinal plants have been an integral part of disease prevention and treatment in both humans and animals worldwide [16,17,18]. Several medicinal plants are known to inhibit the growth or completely inactivate the microbes [19,20,21,22]. Also, some medicinal plants are known to modulate the immune system, which may well be utilized as part of medication for infectious diseases [23]. Phytochemicals may act synergistically with antibiotics, such as blocking efflux pumps and controlling biofilms, which allows low antimicrobial usage and enhanced efficacy [12,24,25,26].
In low-resource setting areas, the lack of modern veterinary services and their inaccessibility have led livestock owners to rely on traditional healers and herbalists [27]. Traditional animal healthcare practices offer low-cost alternatives when commercial drugs and veterinary services are either unavailable or too expensive [28]. In Ethiopia, plants have been used for centuries as a source of medicine to treat various ailments, and traditional medicine is a crucial part of Ethiopian culture [29], in which an estimated 90% of the livestock population is treated with traditional medicines [30]. According to the New Partnership for Africa’s Development, the use of indigenous traditional medicine by the population in Ethiopia is estimated to be between 60% and 79% [31]. The far-reaching utilization of conventional pharmaceuticals in communities of Ethiopia might be credited to social adequacy, viability, physical availability, and financial reasonableness as compared to cutting-edge diarrheal pharmaceuticals [32].
Numerous works showed the distinctive antibacterial and phytochemical constituents of ethnomedicinal plants, suggesting their application in the treatment of infections, especially in dealing with drug-resistant microorganisms [33,34,35]. There has been an extensive use of therapeutic plants with antidiarrheal properties [36]. As of late, many of these therapeutic plants have drawn impressive attention and are being studied to logically assess their antidiarrheal activity. For instance, Calpurnia Aurea, Croton macrostachyus, and Vernonia amygdaline have been tested for their antibacterial efficacy in vitro and in vivo in different countries [37,38,39,40]. Despite these reports, further research on the phytochemicals and antibacterial properties of certain community-used plants is essential in the decision-making of traditional healers. Because phytochemical profiles and antibacterial efficacy of medicinal plants can vary significantly by geographic region, elevation, and ecological conditions [41,42]. This study was conducted to determine the in vitro antibacterial activities and phytochemical constituents of leaf extracts of Vernonia amygdaline, Cordia africana, Calpurnia aurea, Croton macrostachyus, and Melia azedarach against diarrheagenic bacteria in Eastern Hararghe, Ethiopia.

2. Methods and Materials

2.1. Study Area

Jarso area is the Eastern portion of the Hararghe, which is found at around 561 km from Addis Ababa. The Jarso area is additionally one of the 21 sites of East Hararghe. It is separated into 19 Laborer Affiliations and has a range of 487.7 km2. The population is 187000, and the crude population density is 192 people per km2. The bordering areas of Jarso include Harari (south), Dire Dawa (north), Kombolcha (west), and Somali (east), and Gursum (southeast). Topographically, this zone lies between 9024’59.99’’N scope and 42009’60.00’’E longitude. As a result, Jarso is characterized by an ideal agro climatic zones which run in height from 1050 to 3030. Jarso area animals’ populations were 125768 cattle, 7685 sheep, 255780 goats, 4347 camels, 375456 poultry, 57 steeds, 5 donkeys, 8670 nectar bee hives and 5867 jackasses [43].

2.2. Study Setting

2.2.1. Sampling of Diarrheic Calves

Animals that were included in this study were three-month-old calves that were diarrheic and came to the Jarso district veterinary clinic for administration from January 2020 up to July 2021. Fecal samples were collected using sterile test tubes containing buffered peptone water. Parallelly, rectal swabs were taken for direct bacterial culture. All the samples were transported in an icebox under cold chain to the Haramaya University College of Veterinary Medicine Microbiology Research Laboratory.

2.2.2. Experimental Design

An experimental modeling randomized in six (four treatments and two controls) blocks (groups) was arranged for different concentrations of crude extract from medicinal plants (Table 1). Such blocks were prepared for each of the study plant extracts to be tested against the three selected isolates from calf diarrhea.

2.3. Isolation of Test Organism

Diarrheic calves were recruited from the same district to isolate E. coli, Salmonella, and K. pneumoniae. Rectal swab samples were inoculated on MacConkey (MC) agar, followed by Eosin Methylene blue (EMB) agar for E. coli isolation. The isolated colonies were judged based on their cultural characteristics, morphology with Gram’s staining, oxidase test, and biochemical tests such as carbohydrate fermentation, indole, methyl red, H2S production, Voges-Proskauer, urea hydrolysis, and citrate utilization according to Quinn et al. [44]. Isolation and identification of K. pneumoniae followed the same protocol as E. coli, except for the use of EMB agar. Colonies displaying mucoid, lactose-fermenting characteristics were presumptively identified as Klebsiella. For Salmonella detection, rectal swabs were conducted following ISO 6579-1:2017 [45] standard, including pre-enrichment in buffered peptone water (HiMedia), followed by selective enrichment using Rappaport-Vassiliadis broth at the recommended temperature [45]. Loopfuls from both enrichments were plated on XLD agar (red colonies with black centers) and Brilliant Green Agar (red colonies and medium). Presumptive Salmonella colonies were sub-cultured on nutrient agar (Oxoid) and tested for catalase, oxidase, Gram’s reaction, TSI reaction, lysine iron agar, citrate utilization, urease test, and SIM medium reaction. Isolates yielding a TSI profile of alkaline slant/acid butt with H₂S production, positive lysine decarboxylation, positive citrate utilization, negative urea hydrolysis, and negative indole production were confirmed as Salmonella spp. The standard laboratory strains of Salmonella Typhimurium (ATCC 13311), K. pneumoniae (ATCC 700603), and E. coli (ATCC 25922) were utilized from the Ethiopian Public Health Institute (EPHI).

2.4. Identification and Collection of the Plant Materials

Plants were collected from the Jarso area based on their wider application by traditional healers. Thus, five species of plants (Table 2) that have been broadly utilized by local healers in different zones of the Jarso area for the treatment of animal diarrheal diseases were selected in January 2020. After collecting, recognizable proof of the plants was done, and voucher numbers were given by Haramaya University Herbarium (HUHE). The plant leaves were washed with refined water to expel earth and soil particles and subjected to processing. Thus, they were prepared into small pieces and spread out on clean paper sheets, then allowed to dry in a shaded area at room temperature. After approximately two weeks, the dried pieces were collected carefully and ground independently using a crushing machine of an electrical process (GM1001Retsh, Germany). Finally, the fine powder was kept in labeled bottles with air-tight caps at 4 oC for future utilization.

2.5. Crude Extract Preparation

Plant materials were extracted using 99.8% methanol (Ranchem industry, Turkey) by maceration. Thus, 100 g of each powder was mixed with 500 mL of methanol in a flask. The flasks were placed out on an orbital shaker (GFL 3006, Germany) with 80 rpm at room temperature for 72 hours. The extracts were then filtered through Whatman No. 1 filter paper (Unused Delhi, India). The extracts were concentrated under reduced pressure at 37 °C employing a Buchi rotating evaporator (RE-5299 Henan, China). The distinctive extracts were measured and recorded (Eq. 1) before being transferred into labeled vials and stored at 4°C. The sterility of extracts was confirmed by plating on Mueller-Hinton agar (Becton Dickinson and Company, Cockeysville, MD, USA) [46]. The percentage yield of the crude extracts was determined using the following formula:
P e r c e n t a g e   y i e l d = x 1 x 2 y x   100
Where x1 = Weight of container with crude extract, x2 = Empty container, and y = the weight of the soaked powder [47].

2.6. Phytochemical Screening

Unrefined plant extracts were screened for various phytochemical constituents to establish a link between these secondary metabolites and antibacterial activity. Tests were conducted for alkaloids, flavonoids, glycosides, phenolic compounds, saponins, sterols, and tannins using standard methods [48,49] (Supplementary 1).

2.7. Antibacterial Activity Assay of Crude Extracts

2.7.1. Inoculum Standardization

Standard and clinical isolates were inoculated onto a nutrient agar plate medium and incubated for 24 hours at 37 °C. The overnight-grown colonies were used to prepare test suspensions and adjusted to the 0.5 McFarland turbidity standard (~1×108 CFU/ml) according to Clinical and Laboratory Standards Institute [50].

2.7.2. Agar Disc Diffusion

The disc diffusion technique, as described elsewhere [46,50] was used to test the zone of inhibited growth. Whatman No. 1 filter paper was used to create 6 mm diameter discs, which were sterilized at 180 °C for 30 minutes. Three concentrations of crude extracts (780, 390, and 195 mg/ml) were prepared using Dimethyl Sulfoxide (DMSO, 99.2%) as solvent. The fourth concentration was 1000 mg/ml (100%) of crude extract (original extracts). Each sterile disc receives 20 μl of each extract and is left to dry for 30 minutes in room temperature. This was done with a subsequent addition of 10 μl at a time, followed by repeated application after being dried. A bacterial culture suspension (1.5 × 108 CFU/ml) was added to Petri plates of Mueller-Hinton Agar (MHA) medium. The crude extract impregnated discs were then placed on the surface of MHA in triplicate. Negative control discs (DMSO impregnated) and positive control (Gentamicin 10 μg/ml) were used for comparison. After allowing all the plates to stand at room temperature for 30 to 60 minutes, they were incubated at 37 °C for 18-24 hours. The resulting zones of growth inhibition around the discs were measured in millimeters (mm) using a ruler, followed by calculating the mean zones of inhibition.

2.7.3. Minimum Inhibitory Concentration

The minimum inhibitory concentration (MIC) was determined by the tube dilution method [51]. The extracts were diluted to decreasing concentrations (390 mg/mL to 0.76 mg/mL) in serial twofold dilutions using the nutrient broth in tubes. Both positive (bacterial suspension only) and negative control (diluted plant extract) were included. Then, 1 ml of bacterial suspension was transferred to the treatment test tubes. After 24 hrs of incubation at 37°C, the tubes were checked for any evidence of growth (turbidity). The tube with the lowest concentration of the extract with no turbidity (matching the negative control tube) was judged as MIC. All tests were conducted in triplicate, and mean values were recorded for analysis.

2.7.4. Minimum Bactericidal Concentration of Crude Extracts

Test tubes with no turbidity from the MIC test were aseptically sub-cultured to antibacterial-free nutrient agar plates, using a sterile wire loop and incubated at 37ºC for 24h. Then observed for evidence of bacterial colonies. The minimum bactericidal concentration (MBC) was judged as the lowest concentration at which no bacterial colony was observed on the agar plates. All tests were conducted in triplicate, and mean values were recorded for analysis.

2.8. Data Analysis

Data obtained from the test were entered into a Microsoft Excel 2010 spreadsheet, cleaned, and analyzed using Statistical Package for Social Sciences (SPSS version 20, Armonk, NY: IBM Corp). Zone of inhibition, MIC, and MBC were presented using descriptive statistics such as mean and standard error of mean. The difference in the mean value between treatment variables was carried out using one-way ANOVA, followed by Tukey's Post Hoc Multiple Comparison test. The significance level was set at P < 0.05.

3. Results

3.1. Inhibition of Microbial Growth

The current plant extracts have a growth inhibitory effect with a mean zone of inhibition ranging from 10.0 to 21.33 mm (Table 3). The highest record (21.33 mm) was noted with the Vernonia amygdaline (1000 mg/ml) against E. coli and Cordia africana (1000 mg/ml) against Salmonella. Likewise, Calpurnia aurea at 100% concentration shows 20.00 mm inhibition against Klebsiella pneumonia. Also, Vernonia amygdaline at 100% concentration shows 19.33 to 20.00 mm inhibition against Salmonella. The highest activity of Croton macrostachyus extract (1000 mg/ml) was recorded at ~16.00 mm against E. coli (clinical isolate) and Salmonella (standard strain). Regarding Melia azedarach extract, the highest activity was against Salmonella, with 19.67 mm inhibition. Generally, for Calpurnia aurea, Cordia africana, and Vernonia amygdaline, the highest concentration (original extract) exhibited a significantly higher (P < 0.05) inhibition zone than the respective lowest concentration (195 mg/mL). Among the plants, Vernonia amygdaline (1000 mg/ml) showed significantly (P < 0.05) superior activity on clinical isolates of Salmonella and E. coli, while the highest concentration of Calpurnia aurea showed a significantly higher (P < 0.05) inhibition against the standard strain of K. pneumoniae. Melia azedarach and Calpurnia aurea on K. pneumoniae, Vernonia amygdaline on Salmonella and E. coli, showed similar inhibitory activity (P > 0.05) compared with Gentamicin, while the negative control (DMSO) showed no inhibition in all test pathogens. The study also showed susceptibility variations between the clinical isolates and standard strains (Table 3).

3.2. Minimum Inhibitory Concentration

The MIC values of plant extracts ranged from 6.09 mg/mL to 48.75 mg/mL (Table 4). Except for Melia azedarach, all the crude extracts had considerable antibacterial activity, with the lowest MIC value of 6.09 mg/mL against E. coli and 12.18 mg/mL against K. pneumoniae. The MIC value of Melia azedarach was higher for K. pneumoniae (24.38 mg/ml) and E. coli (12.18 mg/ml) than for other plant extracts. With Salmonella (clinical isolate), Melia azedarach showed better activity with a MIC value of 24.38 mg/ml than other plants (48.75 mg/ml).

3.3. Minimum Bactericidal Concentration

The MBC of the extract of the study plant was in the range of 12.18 mg/mL to 97.5 mg/mL (Table 5). The lowest MBC concentration (12.18 mg/ml) was observed by Calpurnia Aurea, Cordia africana, and Vernonia amygdaline against E. coli. Overall, the same MBC values were obtained against standard and clinical isolates (Table 5).

3.4. Phytochemical constituents and characteristics of the crude extracts

The crude extract of plants showed varied reactions for the presence of alkaloids, saponins, tannins, and phenols. But all were negative for the cardiac glycosides, while flavonoids, terpenoids, and steroids were found in all extracts (Table 6). All the crude extracts from the leaves were green, but with varied yields (Table 7). Thus, Calpurnia aurea and Cordia africana leaves yielded the highest, while Croton macrostachyus yielded the lowest.

4. Discussion

To address the shortage of new antibacterial options and the increasing prevalence of antibiotic resistance, plants may offer a promising solution. Evaluating the antibacterial effects of herbal medicines for treating bacterial infections, such as those causing neonatal calf diarrhea, is crucial for addressing animal health issues [52]. The present study evaluated crude plant extracts for their antibacterial activity against K. pneumoniae, Salmonella, and E. coli isolates obtained from cases of diarrhea in calves.
The finding on Vernonia amygdaline against clinical isolates of E. coli (21.33 mm), Salmonella Typhimurium (19.33 mm), and K. pneumoniae (15.33 mm), is agreeable with the values reported in multiple geographic and experimental contexts. Thus, Nmema et al. [53] reported a range from 13-20 mm for K. pneumoniae and 13-18 mm for S. Typhi at various concentrations of ethanol extract using agar well diffusion. Moreover, Sa’idu et al. [54] showed the inhibitory activity of different concentrations of the plant against K. pneumoniae (7-14 mm) using agar well diffusion of methanolic extract. Similarly, Ugwu et al. [55] reported better activity of the plant for E. coli (16 mm) than Klebsiella spp (13 mm) and Salmonella spp (12 mm). Moreover, the observed similarity between the clinical isolate and laboratory strain is in line with the findings of Ugwu et al. [55] on E. coli strains, which showed no difference in zone of inhibition across the test concentration of the plant. Using ethanolic extract, 7-14.5 mm for E. coli, and 7.5 – 11.5 mm for K. pneumoniae [56]. Generally, organisms become more sensitive to the plant extract as the concentration increases [57].
Similarly, Adetunde et al. [58] reported that ethanolic and aqueous extracts of the plant have broad antimicrobial activity (Gram-positive, Gram-negative, yeast), but the ethanol extract showed inhibitory activity against E. coli (19 mm) compared with Salmonella, and only the aqueous extract showed activity against S. Typhi (19 mm). However, contrary to our finding, Ugochi et al. [59] showed better activity of the plant against K. pneumoniae (16.4 mm) than E. coli (14.10 mm) and Salmonella (5.4 mm). Likewise, Jarmai et al. [60] reported a lack of activity of the methanolic extract of the plant against E. coli, while better activity against K. pneumoniae (18 mm) and a moderate value on Salmonella Typhi (9 mm). Using a methanolic extract, 18.0- and 16.0-mm inhibition were recorded for K. pneumoniae and E. coli, respectively, using 4 mg/ml of concentration on agar well diffusion test [61]. As low as 11 mm was recorded for clinical isolates of Salmonella using ethanol extract [62]. Moreover, as low as 7 mm for E. coli and 4 mm for K. pneumoniae was reported using aqueous extract [63]. Using agar well diffusion test, V. amygdalina leaves from Ethiopia have shown antimicrobial activity against the laboratory standard strains, 19.2 mm for E. coli and but no activity for S. Typhi [64].
The observed V. amygdaline MIC value for K. pneumoniae (12.18 mg/ml), E. coli (6.09 mg/ml), and Salmonella (24.38-48.75 mg/ml), which is similar to the value of 6.25 mg/ml for E. coli and 25 mg/ml for Salmonella reported elsewhere [55], 50 mg/ml for Salmonella [62], but it was higher than value of 0.78 for E. coli [64], 5 mg/ml for K. pneumoniae [54], 6.25 mg/ml for Klebsiella [55]. On the other hand, the current finding was lower than the values of 25 mg/ml for E. coli and K. pneumoniae using ethanol extracts [56], value of 50 mg/ml for E. coli and 25 mg/ml for K. pneumoniae [63], 50 mg/ml for K. pneumoniae [60]. The current MBC value for E. coli (12.18 mg/ml), K. pneumoniae (24.38 mg/ml), and Salmonella (48.75 mg/ml) is similar with the MBC value of 25 mg/ml for K. pneumoniae, but lower than the value for E. coli (25 mg/ml) [63], 50 mg/ml for K. pneumoniae [60], and 100 mg/ml for Salmonella [62]. The disparities could be due to different methods of extraction, such as using aqueous extract [63] and ethanol extract [56,62]. The presence of phytochemicals such as tannins, flavonoids, alkaloids, saponins, phenols and terpenoids is in agreement with previous reports [54,55,57,60,61]. Similarly, Ahmad et al. [62] reported that cardiac glycosides are not found in the plant using ethanol extraction. Several compounds from the investigated classes of phytochemicals were reported for their antibacterial activities [57,65]. The yield of Vernonia amygdaline of leaves extract (10.9%) is higher than the percentage reported (7.16%) of Noumedem et al. [66].
The present study underscored the better inhibition zones exhibited by Calpurnia aurea, 15.67-20.00 mm for K. pneumoniae, 15.0-17.67 mm for Salmonella Typhimurium, and 15.33-17.0 mm for E. coli. These results significantly surpass the inhibition zones reported by Umer et al. [38], who found only 10 mm, 11 mm, and 14 mm, respectively, for these bacterial species. It is similar to the 15.63 mm documented by Demeke et al. [67] and 11.47-15.67 mm by Mulatu [68] against E. coli using ethanol extract. Moreover, the current finding is within the range 15 to 19 mm reported by Wasihun et al. [40] using ethanol extract. This suggests a potent efficacy, potentially influenced by factors such as the extraction method and agroecology. Additionally, Calpurnia aurea demonstrated strong effectiveness against Salmonella Typhimurium, aligning with Abise [69], who reported an inhibition zone of 17.66 mm, while higher than 11.5 to 13.23 mm by Mulatu [68] using ethanol extract for the same isolates. Using agar well diffusion test, C. aurea leaves from Ethiopia have shown antimicrobial activity against the laboratory standard strains, 11.0 mm for E. coli and 10.3 mm for S. Typhi [64]. Nevertheless, these findings remain lower than the inhibition zones observed for the antibiotic gentamicin, which measured 19.00 to 29.67 mm for Salmonella. In this study, the MIC values of 12.18 mg/ml (K. pneumoniae), 48.75 mg/ml (Salmonella), and 6.09 mg/ml (E. coli) for Calpurnia aurea differ from Abise [69], who reported an MIC value of 1.25 mg/ml for E. coli. Likewise, 12.5 for S. Typhi and E. coli was reported by Assefa et al. [64]. Extracts with strong antibacterial activity typically had low MIC values, while those with weaker activity had higher MIC values.
This study's phytochemical analysis of Calpurnia aurea leaf extracts revealed the presence of alkaloids, flavonoids, saponins, phenols, tannins, steroids, and terpenoids. Umer et al. [38] and Mulatu [68] also identified these compounds but did not report steroids. The bioactivity of the extracts varied depending on the extraction solvents, geographical source, harvest time, storage conditions, and drying methods [70]. Antibacterial properties are attributed to bioactive compounds like tannins, which may inactivate enzymes and affect microbial adhesion [71]. Flavonoids and saponins also demonstrate antibacterial activity by interacting with protein structures [72]. The extraction yield in this study was 11.9%, slightly higher than 9.1 % (ethanol extract) by Mulatu [68], and 10.02 % by Wasihun et al. [40], suggesting that the secondary metabolites in Calpurnia aurea leaves are predominantly polar. Variations in extraction techniques and plant parts may account for differences in yields. Moreover, a higher percentage (14.64 %) was reported from Ethiopia [64].
The 15 mm zone of inhibition exhibited by Cordia africana extract against clinical isolates of E. coli and K. pneumoniae is lower than the report of Alhadi et al. [73] from Sudan, which showed 18-19 mm zone against E. coli. The MIC of E. coli (6.09 mg/ml) is according to the findings of Alhadi et al. [73], who reported 6.25 mg/ml for the methanol extract of leaves. While lower values were reported, 0.128 mg/ml for S. Typhimurium and 512 mg/ml for E. coli standard strains using methanolic bark extract from Nigeria [74]. These suggest the superior activity of the plant against some pathogens, which is also evidenced by the current observation of the highest inhibition zone of inhibition (21.33 mm) against the standard strain of S. Typhimurium as compared with the other plants. The phytochemical analysis of Methanolic root bark extract of Cordia africana revealed the presence of tannin, flavonoids, terpenoids, and saponins, and the absence of alkaloids in line with the report from Sudan by Alhadi et al. [73]. As compared with the current result on the yield (11.9%), Alhadi et al. [73] recorded a higher extraction percentage yield (15.75%) from methanol extraction of Cordia africana leaves.
In this study, Croton macrostachyus showed a maximum inhibition zone of 16.67 mm and 15.00 mm against clinical and standard E. coli isolates, respectively. In their study, Sendeku et al. [75] reported a higher value of inhibition against standard (25.00 mm) and clinical isolates (20.00 mm) of the same organism using methanol as a solvent. However, far lower values were reported by Jackie et al. [76] on E. coli (9.0 mm) and Salmonella Typhimurium (2.3 mm). The possible reason for the discrepancy between the present finding and other studies could be the difference in the concentration of methanol [77] and plant parts used, where 80% methanol and steam bark were used in the other studies, whereas 99.8% was used in the present study. The current MIC values of Croton macrostachyus extracts against the test pathogens (Table 4) are not in line with a previous report on methanol extracts of leaves and roots of Croton macrostachyus on E. coli with MIC value of 250 mg/ml [78]. The phytochemicals reported in the present study, such as saponins, flavonoids, terpenoids, steroids, and alkaloids, were also reported previously by Alemu et al. [79]. The 7.9% extract yield of Croton Machrostachyus is slightly higher than the report of Kiristos et al. [80], on methanolic stem bark extract (5%). Plant parts (leaf, bark, or root) and their source can influence the quality of an extract [81,82].
Melia azedarach exhibited the highest inhibition at a concentration of 100% against the standard strain of Salmonella (19.67 mm), followed by clinical isolates K. pneumoniae (17.00 mm), E. coli (15.67 mm), and Salmonella (15.33 mm). The current findings, 14.0 mm (390 mg/ml) and 13.0 mm (195 mg/ml) on E. coli, are consistent with the reported range of 12.0 - 16.7 mm (300 mg/ml) and 10.0-13.0 mm (150 mg/ml) from Nigeria [83], but far higher than the reported value of 5.64 mm at 700 mg/ml against E. coli with ethanol extracts elsewhere [84]. The current value for K. pneumoniae (10.33 mm at 195 mg/ml) is lower than the reported value of 12.67 mm at 200 mg/ml for Klebsiella by Al-Khafaji et al. [85], but with different plant parts and extraction method. However, the same authors reported a lower value (7.33 mm) than the current finding (13.00) against E. coli at similar concentrations. The MIC of Melia azedarach against E. coli (12.18 mg/ml) is far lower than the reported value of 1400 mg/ml against E. coli, but with ethanolic extract [84]. Melia azedarach was found to be negative for various phytochemicals (Table 6), which is not in line with the report showing the presence of tannins, saponins, and phenolics [86]. Moreover, the authors reported a 6.72% extraction yield of Melia azedarach methanol leaves extracted, which is lower than the current finding (9%). On the other hand, a similar finding (9.3% yield) from ethanolic extract was reported elsewhere [84].
In the present study, clinical isolates revealed that E. coli exhibited the highest susceptibility to leaf extracts from the five tested plants, followed by Salmonella and K. pneumoniae (Table 3). This variation in susceptibility may be attributed to differences in capsule structure and composition among the bacterial species. Notably, the capsule thickness in K. pneumoniae has been reported to thickest. According to Amak et al. [87] and Schembri et al. [88], the inner layer of the capsule consists of densely packed fiber bundles arranged perpendicularly to the outer membrane. The more robust and complex capsule of K. pneumoniae may contribute to its reduced permeability and resistance to antimicrobial agents, including plant-derived extracts [89,90] Plant secondary metabolites affect the bacterial cells in different ways such as cell wall disruption [91], inhibit biofilm formation and microbial DNA synthesis [92], inhibit energy synthesis, and bacterial toxins production [93,94]. Secondary metabolites also have antidiarrheal activities through different mechanisms, such as inhibition of histamine release by saponins [95], inhibition of autacoids and prostaglandins release by terpenoids [96,97], and astringent action of phenols [95]. The antidiarrheal effect coupled with antibacterial activity may be useful in the management of diarrheal states, especially in conditions where modern antidiarrheal drugs and antibiotics are not available.

5. Conclusion

Ethiopian plants have long been the source of important products with therapeutic value. The agar disc diffusion assay revealed that Vernonia amygdaline, Cordiana africana, Calpurnia aurea, Croton macrostachyus, Melia azedarach demonstrated good antibacterial activities against Salmonella, E. coli, and K. pneumoniae at different concentrations. The significant antibacterial activity against clinical isolates, with E. coli showing the highest susceptibility, followed by Salmonella and K. pneumoniae, justifies their traditional use for the treatment of calf diarrhea infections. Notably, the MBC values in the current study were lower than some previously reported for V. amygdalina, which further supports the potential efficacy. The lower antibacterial concentrations of Vernonia amygdaline, Cordiana africana, and Calpurnia aurea showed for E. coli and K. pneumoniae reinforce the potential of these drugs in treating coliform-associated diarrhea. The inhibitory activity of Vernonia amygdaline, Melia azedarach, and Calpurnia aurea was comparable to gentamicin. These results support the potential of plant-based extracts as alternative or complementary antimicrobial agents, especially in the face of rising antibiotic resistance and limited availability of commercial drugs. Further phytochemical analysis and in vivo studies are recommended to identify active constituents and assess therapeutic applicability and the synergistic or antagonistic effects of active components. For more diversified medicinal uses conservation priority should be given to medicinal plants.

Supplementary Materials

The following supporting information can be downloaded at the website of this paper posted on Preprints.org.

Author Contributions

Nejib Getahun: conceptualization, data curation, investigation, methodology, review & editing. Bruk Abraha: conceptualization, methodology, formal analysis, supervision, validation, visualization, original draft, review & editing. Adem Hiko: conceptualization, methodology, supervision, validation, review & editing.

Funding

Not available.

Authors Declaration

We confirm that all authors agree to be accountable for the research presented.

Availability Of Data

The data of this study are available from the corresponding author upon request.

Ethics Approval and Consent to Participate

Not applicable.

Acknowledgements

We are grateful to the College of Agriculture and Environmental Sciences and the Department of Plant Pathology Research Laboratory, Haramaya University, for allowing us to use the laboratory for plant extraction. Ms. Haymanot is appreciated for her technical assistance in laboratory work. We are also thankful to the College of Veterinary Medicine, Veterinary Microbiology laboratory staff facilitation during the isolation of bacteria.

Conflict of Interest

The authors declare no conflict of interest.

References

  1. Berchtold, J. F.; & Constable, P. D. F.; & Constable, P. D. Antibiotic Treatment of Diarrhea in Preweaned Calves. Food Animal Practice 2009, 520–525. [Google Scholar] [CrossRef]
  2. Rajat, S.; Amit, K. V.; Amit, K.; Arbind, S.; Aditya, K.; & Afroz, T. K. Prevalence and Antimicrobial Resistance of Klebsiella species Associated with Bovine Diarrhea. In Biol. Forum Inter. J. 2022, 14, 581–585. [Google Scholar]
  3. Bernal-Córdoba, C.; Branco-Lopes, R.; Alonso-López, Y.; Minjee-Lee, C.; Pérez-Solano, D.; Fausak, E. D.; V Pereira, R.; & Silva-Del-Río, N. Antimicrobial drugs used in the prevention and control of protozoal and bacterial calf diarrhea: A scoping review. Preventive veterinary medicine 2025, 241, 106543. [Google Scholar] [CrossRef]
  4. Rima, A.; Moghnieh, J.A.; Moussa, M. A.; Aziz Ghassan, M. ; Matar. Phenotypic and Genotypic Characterization of Cephalosporin-, Carbapenem, and Colistin-Resistant Gram-Negative Bacterial Pathogens in Lebanon, Jordan, and Iraq. Journal of Global Antimicrobial Resistance 2021.
  5. Ababu, A.; Endashaw, D.; Fesseha, H. Isolation and Antimicrobial Susceptibility Profile of Escherichia Coli O157 : H7 from Raw Milk of Dairy Cattle in Holeta District, Central Ethiopia. International Journal of Microbiology 2020, 1–8. [Google Scholar] [CrossRef]
  6. Hailu, S. Isolation, Identification and Antibiotic Susceptibility of E.coli from Diarrheic Calves in and Around Holeta Town, Central Ethiopia. J Vet Med Res 2020, 7, 1197. [Google Scholar]
  7. Minda Asfaw, G. , & Shimelis, R. E. coli O15: H7 from food of animal origin in Arsi: Occurrence at catering establishments and antimicrobial susceptibility profile. The Scientific World Journal.
  8. Fesseha, H.; Mathewos, M.; Aliye, S.; & Mekonnen, E. Isolation and antibiogram of E. coli O157: H7 from diarrhoeic calves in urban and peri-urban dairy farms of Hawassa town. Veterinary medicine and science 2022, 8, 864–876. [CrossRef]
  9. Wale, Y.; & Kassa, T. Antimicrobial susceptibility pattern of E. coli isolated from dairy calves with diarrhoea in Akaki Kality, Addis Ababa, Ethiopia. Journal of Applied Animal Research 2023, 51, 470–476. [Google Scholar] [CrossRef]
  10. Pomba, C.; Rantala, M.; Greko, C.; Baptiste, K.E.; Catry, B.; Van Duijkeren, E.; Mateus, A.; Moreno, M.A.; Pyörälä, S.; Ružauskas, M. Public health risk of antimicrobial resistance transfers from companion animals. Antimicrobial Agents Chemotherapy 2017, 72, 957–968. [Google Scholar] [CrossRef] [PubMed]
  11. Belete, M.A.; Demlie, T.B.; Chekole, W.S.; Sisay Tessema, T. Molecular identification of diarrheagenic E. coli pathotypes and their antibiotic resistance patterns among diarrheic children and in contact calves in Bahir Dar city, Northwest Ethiopia. PLoS ONE 2022, 17, e0275229. [Google Scholar] [CrossRef] [PubMed]
  12. Borges, A.; Abreu, A. C.; Dias, C.; Saavedra, M. J.; Borges, F.; & Simões, M. New Perspectives on the Use of Phytochemicals as an Emergent Strategy to Control Bacterial Infections Including Biofilms. Molecules (Basel, Switzerland) 2016, 21, 877. [Google Scholar] [CrossRef]
  13. Khameneh, B.; Eskin, N. A. M.; Iranshahy, M.; & Fazly Bazzaz, B. S. Phytochemicals: A Promising Weapon in the Arsenal against Antibiotic-Resistant Bacteria. Antibiotics 2021, 10, 1044. [Google Scholar] [CrossRef]
  14. Williamson, E.M. Synergy and other interactions in phytomedicines. Phytomedicine 2001, 8, 401–409. [Google Scholar] [CrossRef]
  15. Wagner, H.; Ulrich-Merzenich, G. Synergy research: approaching a new generation of phytopharmaceuticals. Phytomedicine 2009, 16, 97–110. [Google Scholar] [CrossRef]
  16. Rawat, P.; Singh, P. K.; & Kumar, V. Evidence based traditional anti-diarrheal medicinal plants and their phytocompounds. Biomedicine & pharmacotherapy 2017, 96, 1453–1464. [Google Scholar] [CrossRef]
  17. Oda, B.K.; Lulekal, E.; Warkineh, B.; Asfaw, Z.; & Debella, A. K.; Lulekal, E.; Warkineh, B.; Asfaw, Z.; & Debella, A. Ethnoveterinary medicinal plants and their utilization by indigenous and local communities of Dugda District, Central Rift Valley, Ethiopia. J Ethnobiology Ethnomedicine 2024, 20, 32. [Google Scholar] [CrossRef]
  18. Plaatjie, M. T. A.; Onyiche, T. E.; Ramatla, T.; Bezuidenhout, J. J.; Legoabe, L.; Nyembe, N. I.; & Thekisoe, O. A.; Onyiche, T. E.; Ramatla, T.; Bezuidenhout, J. J.; Legoabe, L.; Nyembe, N. I.; & Thekisoe, O. A scoping review on efficacy and safety of medicinal plants used for the treatment of diarrhea in sub-Saharan Africa. Tropical medicine and health 2024, 52, 6. [Google Scholar] [CrossRef] [PubMed]
  19. Sisay, M.; Bussa, N.; Gashaw, T.; & Mengistu, G. Investigating In Vitro Antibacterial Activities of Medicinal Plants Having Folkloric Repute in Ethiopian Traditional Medicine. Journal of evidence-based integrative medicine 2019, 24, 2515690X19886276. [Google Scholar] [CrossRef]
  20. Manilal, A.; Sabu, K. R.; Shewangizaw, M.; Aklilu, A.; Seid, M.; Merdikios, B.; & Tsegaye, B. In vitro antibacterial activity of medicinal plants against biofilm-forming methicillin-resistant Staphylococcus aureus: efficacy of Moringa stenopetala and Rosmarinus officinalis extracts. Heliyon 2020, 6, e03303. [Google Scholar] [CrossRef]
  21. Gadisa, E.; & Tadesse, E. Antimicrobial activity of medicinal plants used for urinary tract infections in pastoralist community in Ethiopia. BMC complementary medicine and Therapies 2021, 21, 74. [Google Scholar] [CrossRef] [PubMed]
  22. Nourmohammadi Ghezelghaye, P.; Alibegli, M.; Fazelnejad, A.; Davoodi, A.; & Goli, H. R. Antibacterial activity of tannin-free ethanolic extracts from medicinal plants against methicillin-resistant Staphylococcus aureus. BMC Complement Med Ther 2025, 25, 271. [Google Scholar] [CrossRef]
  23. Ayrle, H.; Mevissen, M.; Kaske, M. Nathues, H, Gruetzner, N.; Melzig, M.; and Walkenhorst, M. Medicinal plants prophylactic and therapeutic options for gastrointestinal and respiratory diseases in calves and piglets. A systematic review. BMC Veterinary Research 2016. [Google Scholar] [CrossRef] [PubMed]
  24. Zuo, GY.; Yang, CX.; Ruan, ZJ.; et al. Potent anti-MRSA activity and synergism with aminoglycosides by flavonoid derivatives from the root barks of Morus alba, a traditional Chinese medicine. Med Chem Res. 2019, 28, 1547–1556. [Google Scholar] [CrossRef]
  25. Gupta, R.; & Sharma, S. Role of alternatives to antibiotics in mitigating the antimicrobial resistance crisis. The Indian journal of medical research 2022, 156, 464–477. [Google Scholar] [CrossRef]
  26. Gonçalves, A.S.C.; Leitão, M.M.; Simões, M.; Borges, A. The action of phytochemicals in biofilm control. Nat Prod Rep 2023, 40, 595–627. [Google Scholar] [CrossRef]
  27. Salmer, E.; Garrido-cardenas, J. A.; and Manzano-agugliaro, F. Worldwide Research Trends on Medicinal Plants. International Journal of Environmental Research and Public Health 2020, 17, 3376. [Google Scholar] [CrossRef] [PubMed]
  28. Galav, P.; Jain, A.; and Katewa, S. S. Traditional veterinary medicines used by livestock owners of Rajasthan, India. Indian Journal Traditional Knowledge 2013, 12, 47–55. [Google Scholar]
  29. Belay, H.; and Wondimu, T. Functional food plants in Debre Markos district, East Gojjam, Ethiopia. Asian Journal of Ethnobiology 2019, 2, 8–21. [Google Scholar] [CrossRef]
  30. Oyda, S. Review On Traditional Ethnoveterinary Medicine and Medicinal Plants Used by Indigenous People in Ethiopia: Practice and Application System. International Journal of Research-Granthaalayah 2017, 5, 109–119. [Google Scholar] [CrossRef]
  31. WHOGRTCM (World Health Organization Global Report on Traditional and Complementary Medicine). Geneva, Switzerland: World Health Organization. 2019.
  32. Gebremedhin, G.; Shewit, D.; Samson, S.; Shewit, D. ; Samson, S. An ethno-veterinary survey of medicinal plants in Woredas of Tigray region, Northern Ethiopia. International Journal of Biodiversity 2013, 1, 120–132. [Google Scholar]
  33. Kebede, T.; Gadisa, E.; & Tufa, A. Antimicrobial activities evaluation and phytochemical screening of some selected medicinal plants: A possible alternative in the treatment of multidrug-resistant microbes. PLOS One 2021, 16, e0249253. [Google Scholar] [CrossRef]
  34. Ashraf, M. V.; Pant, S.; Khan, M. A. H.; Shah, A. A.; Siddiqui, S.; Jeridi, M.; Alhamdi, H. W. S.; & Ahmad, S. V.; Pant, S.; Khan, M. A. H.; Shah, A. A.; Siddiqui, S.; Jeridi, M.; Alhamdi, H. W. S.; & Ahmad, S. Phytochemicals as Antimicrobials: Prospecting Himalayan Medicinal Plants as Source of Alternate Medicine to Combat Antimicrobial Resistance. Pharmaceuticals (Basel, Switzerland) 2023, 16, 881. [Google Scholar] [CrossRef]
  35. Jia, D.; Arbab, S.; Ullah, H.; Alzahrani, K. J.; Alzahrani, F. M.; Alsharif, K. F.; Zhang, J.; & Li, K. Antibacterial Activity of Traditional Medicinal Plants: Combating Antibiotics Resistance in Animal Wound Infections. Veterinary Medicine and Science 2025, 11, e70361. [Google Scholar] [CrossRef] [PubMed]
  36. Palombo, E.A. Phytochemicals from traditional medicinal plants used in the treatment of diarrhoea: modes of action and effects on intestinal function. Phytotherapy Research 2006, 20, 717–724. [Google Scholar] [CrossRef]
  37. Adedapo, A.A.; Jimoh, F.O.; Koduru, S.; Afolayan, A.J.; and Masika, P.J. A.; Jimoh, F.O.; Koduru, S.; Afolayan, A.J.; and Masika, P.J. Antibacterial and antioxidant properties of the methanol extracts of the leaves and stems of Calpurnia aurea. BMC Complementary and Alternative Medicine 2008, 8, 8–53. [Google Scholar] [CrossRef]
  38. Umer, S.; Tekewe, A.; and Kebede, N. Antidiarrheal and antimicrobial activity of Calpurnia aurea leaf extract. BMC Complementary and Alternative Medicine 2013, 13. [Google Scholar] [CrossRef]
  39. Voukeng, I.K.; Beng, V.P.; and Kuete, V. K.; Beng, V.P.; and Kuete, V. Antibacterial activity of six medicinal Cameroonian plants against Gram-positive and Gram-negative multidrug resistant phenotypes. BMC Complementary and Alternative Medicine 2016, 16, 388. [Google Scholar] [CrossRef]
  40. Wasihun, Y.; Alekaw Habteweld, H.; & Dires Ayenew, K. Antibacterial activity and phytochemical components of leaf extract of Calpurnia aurea. Scientific Reports 2023, 13, 9767. [Google Scholar] [CrossRef]
  41. Djouahri, A.; Boualem, S.; Boudarene, L.; & Baaliouamer, A. Geographic's variation impact on chemical composition, antioxidant and anti-inflammatory activities of essential oils from wood and leaves of Tetraclinis articulata (Vahl) Masters. Industrial Crops and Products 2015, 63, 138–146. [Google Scholar] [CrossRef]
  42. Oncho, D.A.; Ejigu, M.C. A.; Ejigu, M.C. & Urgessa, O.E. Phytochemical constituent and antimicrobial properties of guava extracts of east Hararghe of Oromia, Ethiopia. Clin Phytosci. 2021, 7, 37. [Google Scholar] [CrossRef]
  43. JWLRDO (Jarso Woreda Livestock Resource Development Office). Reports of Jarso Woreda Livestock Resource Development Office 2021.
  44. Quinn, P. J.; Markey, B. K.; Leonard, F. C.; FitzPatrick, E. S.; Fanning, S.; and Hartigan, P. J. Veterinary Microbiology and Microbial Disease Second edition. Oxford, Wiley-Blackwell. 2011. pp. 912.
  45. ISO 6579-1:2017. Microbiology of the food chain — Horizontal method for the detection, enumeration and serotyping of Salmonella Part 1: Detection of Salmonella spp. International Organization for Standardization, Geneva.
  46. Bauer, A.W.; Kirby W., M.; Sherris J., C. W.; Kirby W. M.; Sherris J. C.; and Turck. M.; Antibiotic Susceptibility Testing by a Standardized Single Disk Method. American Journal of Clinical Pathology 1966, 45, 493–496. [Google Scholar] [CrossRef] [PubMed]
  47. Parekh, J.; Chanda, S.V. In vitro Antimicrobial Activity and Phytochemical Analysis of Some Indian Medicinal Plants. Turkey Journal of Biology 2007, 31, 53–58. [Google Scholar]
  48. Trease, G.E.; and Evans, W.C. Pharmacognosy, W. B. Scandars, London. Bailliere Tindall, 1989. pp. 45–50.
  49. Sofowora, A. Medicinal Plants and Traditional Medicines in Africa, Spectrum Books Ltd.; Sunshine House, Ibadan, Nigeria. 1993.
  50. CLSI (Clinical Laboratory and Standard Institute). M100 performance standards for antimicrobial susceptibility testing, CLSI, Wayne, USA, 30th edition. 2020.
  51. Mummed, B.; Abraha, A.; Assefa, S.; Feyera, T.; and Nigusse, A. In Vitro Antibacterial Activity of Selected Medicinal Plants in the Traditional Treatment of Skin and Wound Infections in Eastern Ethiopia. BioMed Research International 2018, 1, 1862401. [Google Scholar] [CrossRef]
  52. Smulski, S.; Turlewicz-Podbielska, H.; Wylandowska, A.; and Włodarek, J. Non-antibiotic possibilities in prevention and treatment of calf diarrhoea. Journal of Veterinary Research 2020, 64, 119–126. [Google Scholar] [CrossRef]
  53. Nmema, E.E.; Oladimeji, A.O.; Akinmade, R.F. O.; Akinmade, R.F. and Akinnusi, P.O. Activities of leaves extracts of Vernonia amygdalina and Abrus precatorius against selected antibiotic resistant bacterial pathogens. Scientia Africana 2023, 22, 95–106. [Google Scholar] [CrossRef]
  54. Sa’idu, H.; Ahmad, H. I.; Olanrewaju, S. A.; & Mahmoud, A. B. Antibacterial Effect of Bitter Leave (Vernonia amygdalina) on K. pneumoniae. Journal of Biochemistry, Microbiology and Biotechnology 2020, 8, 16–20. [Google Scholar] [CrossRef]
  55. Ugwu, C.A.; Mbah-Omeje, C.C.; Ozochi, K.N. C.; Ozochi, K.N. Antibacterial Efficacy of Vernonia Amygdalina (Bitter Leaf) on Some Bacteria Isolated from Locally Produced Soymilk Sold in Different Markets in Enugu Metropolis. International Journal Of Innovative Research & Development 2023, 12, 13–20. [Google Scholar]
  56. Evbuomwan, L.; Chukwuka, E. P.; Obazenu, E. I.; & Ilevbare, L. Antibacterial activity of Vernonia amygdalina leaf extracts against multidrug-resistant bacterial isolates. Journal of applied sciences and environmental management 2018, 22, 17–21. [Google Scholar] [CrossRef]
  57. Abike, T. O.; Debbie, O.; Olusola, O. C.; Modupe, A. O.; Boyede, D.; and A, O. A. O.; Debbie, O.; Olusola, O. C.; Modupe, A. O.; Boyede, D.; and A, O. A. Antibacterial Efficacy of Vernonia Amygdalina Against Bacteria Strains Recovered from Hospital Fomites, Nigeria. Current Trends on Biotechnology & Microbiology 2020, 2, 381–388. [Google Scholar]
  58. Adetunde, L. A.; Ninkuu, V.; Sacky, I. A.; Ninkuu, V.; Sacky, I. Evaluating the antimicrobial potency of crude extracts of Psidium guajava bark, leaves of Vernonia amygdalina, Carica papaya and whole plant of Phyllanthus niruri against specific pathogenic bacteria. J. Bacteriol. Res. 2017, 9, 15–20. [Google Scholar] [CrossRef]
  59. Ugochi, U. J.; Obinna, A. C.; Emeka, E. A.; Oluchi, A. E.; Makeri, D.; Theophilus, P.; & Agwu, E. J.; Obinna, A. C.; Emeka, E. A.; Oluchi, A. E.; Makeri, D.; Theophilus, P.; & Agwu, E. Therapeutic potential of Chromolaena odorata, Vernonia amygdalina, and Cymbopogon citratus against pathogenic Bacteria. Scientific Reports 2025, 15, 217. [Google Scholar] [CrossRef]
  60. Jarmai, Adamu Hassan, Abdullahi Mohammed Sheikh, ThankGod E. Onyiche, Harun Yunus, Mustapha Abba Aji, and Sadiya Mohammed Umar. Antimicrobial Activity and Phytochemical Screening of Methanolic Leaf Extract of Vernonia Amygdalina. South Asian Journal of Research in Microbiology 2022, 14, 23–35. [CrossRef]
  61. Adebayo, O. L.; James, A.; Kasim, S. B. L.; James, A.; Kasim, S. B. and Jagri, O. P. Leaf Extracts of Vernonia amygdalina Del. from Northern Ghana Contain Bioactive Agents that Inhibit the Growth of Some Beta-lactamase Producing Bacteria in vitro. Journal of Pharmaceutical Research International 2013, 4, 192–202. [Google Scholar] [CrossRef]
  62. Ahmad, M.; Usman, A.; & Usman, H. D. Antibacterial Activity of Vernonia Amygdalina (Bitter Leaf) Extracts against Clinical Isolates of Salmonella Species. UMYU Journal of Microbiology Research 2024, 9, 308–314. [Google Scholar]
  63. Magaji, A.; Mahmud, Z.; & Mustafa, A. Phytochemical analysis and assessment of antibacterial efficacy of Vernonia amygdalina (Bitter Leaf) against some selected clinical bacterial isolates. UMYU Journal of Microbiology Research 2023, 8, 174–180. [Google Scholar] [CrossRef]
  64. Assefa, A.; Belay, S.; & Kloos, H. Evaluation of in-vitro antibacterial activity of extracts of Calpurina aurea, Vernonia amygdalina and Rumex nepalensis in Goba district, southeastern Ethiopia. Egyptian Journal of Basic and Applied Sciences 2024, 11, 69–83. [Google Scholar] [CrossRef]
  65. Zubairu, A.Y.; Mukhtar, M.; Saidu, I.; Ibrahim, Z.; Isah, S.; Garga, M.A. Y.; Mukhtar, M.; Saidu, I.; Ibrahim, Z.; Isah, S.; Garga, M.A. and Kebbi, H.S. Antibacterial activity of methanolic extract of bitter leaf (Vernonia amygdalina) from various component fractions using column chromatography. GSC Biological and Pharmaceutical Sciences 2019, 7, 16–21. [Google Scholar] [CrossRef]
  66. Noumedem. J.A.K.; Mihasan, M.; Kuiate, J.R.; Stefan, M.; Cojocaru, D. In Vitro antibacterial and antibiotic-potentiation activities of four edible plants against multidrug-resistant gram-negative species. BMC Complementary and Alternative Medicine 2013, 13, 19. [Google Scholar]
  67. Demeke, D.; Mastewal, B.; Amebaye, K.; and Muluken, Y. Assessments of Antibacterial Effects of Aqueous-Ethanol Extracts of Sida rhombifolia’s Aerial Part. The Scientific World Journal 2018, 1, 8429809. [Google Scholar]
  68. Mulatu, G. Antibacterial Activities of Calpurnia aurea against Selected Animal Pathogenic Bacterial Strains. Advances in pharmacological and pharmaceutical sciences 2020, 8840468. [Google Scholar] [CrossRef] [PubMed]
  69. Abise, Z. Antibacterial Activity of the Extracts of the Leaves and Stem Barks of Calpurnia aurea Against Selected Human Pathogenic Bacteria. MSc. Thesis, Adama University, Adama, Ethiopia. 2020. [Google Scholar]
  70. Tanver, A.; Peng, M.; Hongxin, G. Anti-quorum sensing and anti-biofilm activity of Amomumtsaoko on foodborne pathogens. Saudi Journal of Biological Sciences 2017, 24, 3–12. [Google Scholar]
  71. Farhadi, F.; Khameneh, B.; Iranshahi, M.; and Iranshahi, M. Antibacterial activity of flavonoids and their structure activity relationship: An update review. Phytotherapy Research. 2019, 33, 13–40. [Google Scholar] [CrossRef]
  72. Achika, J. I.; Ayo, R. G.; Oyewale, A. O.; and Habila, J. D. I.; Ayo, R. G.; Oyewale, A. O.; and Habila, J. D. Flavonoids with antibacterial and antioxidant potentials from the stem bark of Uapaca heudelotti. Heliyon 2020, e03381. [Google Scholar] [CrossRef] [PubMed]
  73. Alhadi, E.A.; Khalid, H.S.; Alhassan, M.S.; Kabbashi, A.S.; and Noor, M.O. A.; Khalid, H.S.; Alhassan, M.S.; Kabbashi, A.S.; and Noor, M.O. Antimicrobial and phytochemical screening of Cordia Africana in Sudan. World Journal of Pharmacy Research 2015, 4, 257–269. [Google Scholar]
  74. Isa, A. I.; Saleh, M. I. A.; Abubakar, A.; Dzoyem, J. P.; Adebayo, S. A.; Musa, I.; & Daru, P. A. I.; Saleh, M. I. A.; Abubakar, A.; Dzoyem, J. P.; Adebayo, S. A.; Musa, I.; & Daru, P. A. Evaluation of anti-inflammatory, antibacterial and cytotoxic activities of Cordia africana leaf and stem bark extracts. Bayero Journal of Pure and Applied Sciences 2016, 9, 228–235. [Google Scholar]
  75. Wagay Sendeku, Bewekete Alefew, Dejenie Mengiste, Kassahun Seifu, Shito Girma, Elsabet Wondimu. Antibacterial activity of croton macrostachyus against some selected pathogenic bacteria. Biotechnology International 2015, 8, 11–20. [Google Scholar]
  76. Jackie, K.; Obey A., W.; Jimmy, O.; Jussi, K.; Carina, T.K. Antimicrobial Activity of Croton macrostachyus Stem Bark Extracts against Several Human Pathogenic Bacteria. Hindawi Publishing Corporation Journal of Pathogens 2016, 2, 516–522. [Google Scholar]
  77. Bimakr, M. Comparison of different extraction methods for the extraction of major bioactive flavonoid compounds from spearmint (Mentha spicata L.) leaves. Food Bio Product Process 2010, 1, 6. [Google Scholar] [CrossRef]
  78. Wagate, G. Cyrus; Gakuya, W. Daniel; Mark, O. Nanyingi; Francis, K. Njonge; James M Mbaria. Antibacterial and cytotoxic activity of Kenyan medicinal plants. Memorials do Institute Oswaldo Cruz, Rio de Janeiro 2008, 103, 650–652. [Google Scholar]
  79. Alemu, A.; Mathewos, A.; Desta, E.; Ashenafi, K.; Gewado, A.; Kagnuro, G. In-vitro and In-vivo antibacterial activities of Croton macrostachyus methanol extract against E. coli and Staphylococcus aureus. Advanced Animal Veterinary Science 2017, 5, 107–14. [Google Scholar]
  80. Kiristos, T. G.; Mengesha, Z. T.; Kebede, A.; and Chaithanya, K. K. G.; Mengesha, Z. T.; Kebede, A.; and Chaithanya, K. K. Phytochemical screening and evaluation of antibacterial activities of Croton macrostachyus stem bark extracts. Drug Invention Today 2018, 10, 2727–2733. [Google Scholar]
  81. Millogo-Kone, H.; Guissou, I. P.; Nacoulma, O.; & Traore, A. S. Comparative study of leaf and stem bark extracts of Parkia biglobosa against enterobacteria. African journal of traditional, complementary, and alternative medicines: AJTCAM 2008, 5, 238–243. AJTCAM 2008, 5, 238–243. [Google Scholar] [CrossRef] [PubMed]
  82. Verma, N.; Shukla, S. Impact of various factors responsible for fluctuation in plant secondary metabolites. JARMAR 2015, 2, 113. [Google Scholar] [CrossRef]
  83. Touzout, S. N.; Merghni, A.; Laouani, A.; Boukhibar, H.; Alenazy, R.; Alobaid, A.; Alenazy, M.; Ben-Attia, M.; Saguem, K.; & El-Bok, S. N.; Merghni, A.; Laouani, A.; Boukhibar, H.; Alenazy, R.; Alobaid, A.; Alenazy, M.; Ben-Attia, M.; Saguem, K.; & El-Bok, S. Antibacterial Properties of Methanolic Leaf Extracts of Melia azedarach L. against Gram-Positive and Gram-Negative Pathogenic Bacteria. Microorganisms 2023, 11, 2062. [Google Scholar] [CrossRef]
  84. Obat, R.; Shiundu, M.; Gikaru, R.; Bett, C.; & Ouma, S. E. coli. African Journal of Pharmacy and Alternative Medicine 2023, 1, 12–20. [Google Scholar] [CrossRef]
  85. Al-Khafaji, N. J.; Al-Zubaedi, R. M.; & Al-Azawi, S. J. J.; Al-Zubaedi, R. M.; & Al-Azawi, S. J. Evaluation of antibacterial effects of melia azedarach fruit extracts against some isolated pathogenic bacteria. Veterinary Science Development 2016, 6. [Google Scholar] [CrossRef]
  86. Deb, K.; Kaur, A.; Ambwani, S.; and Ambwani, T. K. Preliminary phytochemical analyses of hydromethanolic leaf extract of Melia azedarach L. Journal of Medicinal Plants Study 2018, 6, 4–8. [Google Scholar]
  87. Amak, K.; Meno, Y.; Takade, A. Fine Structures of the Capsules of K. pneumoniae and E. coli K1. J Bacteriol. 1988, 170, 4960–4962. [Google Scholar] [CrossRef]
  88. Schembri, M. A.; Blom, J.; Krogfelt, K. A.; and Klemm, P. A. ; Blom, J.; Krogfelt, K. A.; and Klemm, P. Capsule and Fimbria Interaction in Klebsiella pneumonia. Infection and immunity 2005, 73, 4626–4633. [Google Scholar] [PubMed]
  89. Diago-Navarro, E.; Chen, L.; Passet, V.; Burack, S.; Ulacia-Hernando, A.; Kodiyanplakkal, R. P.; Levi, M. H.; Brisse, S.; Kreiswirth, B. N.; & Fries, B. C. Carbapenem-resistant K. pneumoniae exhibit variability in capsular polysaccharide and capsule-associated virulence traits. The Journal of Infectious Diseases 2014, 210, 803–813. [Google Scholar] [CrossRef]
  90. Paczosa MK, Mecsas J..K. pneumoniae: Going on the Offense with a Strong Defense. Microbiol Mol Biol Rev. 2016, 80. [CrossRef]
  91. Cowan, M.M. Plant Products as Antimicrobial Agents. Clin Microbiol Rev. 1999, 12. [Google Scholar] [CrossRef] [PubMed]
  92. Savoia, D. Plant-derived antimicrobial compounds: Alternatives to antibiotics. Future Microbiology 2012, 7, 979–990. [Google Scholar] [CrossRef]
  93. Awolola, G.V.; Koorbanally, N.A.; Chenia, H.; Shode, F.O.; Baijnath, H. V.; Koorbanally, N.A.; Chenia, H.; Shode, F.O.; Baijnath, H. Antibacterial and Anti-Biofilm Activity of Flavonoids and Triterpenes Isolated from The Extracts of Ficus Sansibarica Warb. Subsp. Sansibarica (Moraceae) Extracts. African Journal of Traditional, Complementary and Alternative Medicine 2014, 11, 124. [Google Scholar] [CrossRef]
  94. Gorniak, I.; Bartoszewski, R.; Króliczewski, J. Comprehensive review of antimicrobial activities of plant flavonoids. Phytochemicals. Review 2019, 18, 241–272. [Google Scholar] [CrossRef]
  95. Megersa, A.; Dereje, B.; Adugna, M.; Ayalew Getahun, K.; & Birru, E. M. Evaluation of Anti-Diarrheal Activities of the 80% Methanol Extract and Solvent Fractions of Maesa lanceolata Forssk (Myrsinaceae) Leaves in Mice. Journal of Experimental Pharmacology 2023, 15, 391–405. [Google Scholar] [CrossRef] [PubMed]
  96. Xie, Y.; Yang, W.; Tang, F.; Chen, X.; & Ren, L. Antibacterial activities of flavonoids: structure-activity relationship and mechanism. Current medicinal chemistry 2015, 22, 132–149. [Google Scholar] [CrossRef]
  97. Zewdie, K.A.; Bhoumik, D.; Wondafrash, D.Z. A.; Bhoumik, D.; Wondafrash, D.Z. & Tuem, K. B. Evaluation of in-vivo antidiarrhoeal and in-vitro antibacterial activities of the root extract of Brucea antidysenterica J. F. Mill (Simaroubaceae). BMC complementary medicine and therapies 2020, 20, 201. [Google Scholar] [CrossRef]
Table 1. Experimental treatment for assessing the mean zone of inhibition.
Table 1. Experimental treatment for assessing the mean zone of inhibition.
Group Treatment Concentration (mg/mL)
i leave extract 1000 (Original extract)
ii leave extract 780
iii leave extract 390
iv leave extract 195
v +ve control (Gentamicin 10 µg) Not applicable
vi -ve control (DMSO 99.2 %) Not applicable
Table 2. Medicinal Plants Employed in the Jarso district for treatment of Calf Diarrhea.
Table 2. Medicinal Plants Employed in the Jarso district for treatment of Calf Diarrhea.
Scientific name Local name Family name Parts used Voucher No
Calpurnia aurea Ceekaa Polygonaceae Leaf HUHE0000009429
Melia azedarach Kiniinaa Meliaceae Leaf HUHE00000010959
Cordia africana Waddeeysa Boraginaceae Leaf HUHE0000002154
Croton macrostachyus Makkanniisa Fabaceae Leaf HUHE0000006858
Vernonia amygdaline Eebichaa Asteraceae Leaf HUHE0000005110
HUHE = Haramaya University Herbarium.
Table 3. The zone (mean ± SEM) of bacterial growth inhibition (mm) using different concentrations of crude plant extracts compared with standard antibacterial drugs.
Table 3. The zone (mean ± SEM) of bacterial growth inhibition (mm) using different concentrations of crude plant extracts compared with standard antibacterial drugs.
Plants Concentrations (mg/ml) K. pneumonia Salmonella E. coli
Clinical Standard Clinical Standard Clinical Standard
Calpurnia aurea 1000 15.67±0.3b 20.00±0.6a,b 15.00±0.0f 17.67±1.2b,f 17.0 ±0.3 15.33±0.3
780 13.00±0.0c 16.00±2.5c 14.33±0.3cz 15.67±0.3c 14.5±0.3 15.33±0.3
390 13.00±0.6d 13.00±0.6d 14.00±0.6d 14.00±0.6d 14.5±0.5d 15.00±0.6d
195 11.00±0.0e 11.67±0.3e 13.00±0.0e 12.67±0.3e 13.0±0.3e 13.33±0.3e
Cordia africana 1000 15.00±0.6b 12.00±0.0 13.00±0.3f,g 21.33±0.9b 15.5±0.3 14.00±0.6
780 12.33±0.9c 13.00±0.6c 14.33±0.3d 13.33±0.3c 14.67±0.3 13.67±0.7
390 12.33±1.2d 12.00±0.6d 14.00±0.3cz 14.00±0.6d 14.3±0.9d 13.00±0.0d
195 11.00±0.0e 11.00±0.0 12.00±0.3 12.33±0.3e 13.67±0.3e 12.00±0.0e
Croton macrostachyus 1000 14.33±0.3 13.00±0.6 15.00±0.0f 15.00±0.0f 16.67±0.3 15.00±0.0
780 12.00±0.0c 12.67±0.3c 14.00±0.6cz 15.33±0.3c 14.67±0.3 14.67±0.3
390 11.67±0.3d 12.00±0.6d 15.33±0.3d 15.00±0.6d 15.00±0.6d 14.00±0.0d
195 10.00±0.0e 11.00±0.6e 14.00±0.0e 13.00±0.0e 14.00±0.0e 12.00±0.0e
Melia azedarach 1000 17.00±0.0ab 15.33±0.3 14.33±0.3f,g 19.67±0.3b 15.67±0.3 15.33±0.3
780 13.00±0.0c 13.00±0.0c 13.33±0.3z 15.00±0.0c 15.00±0.0 14.00±0.0
390 12.00±0.0d 11.00±0.6d 14.00±0.0d 14.00±0.0d 15.00±0.0d 13.00±0.0d
195 10.33±0.3e 10.00±0.0e 12.00±0.0 12.00±0.0e 13.00±0.0e 12.00±0.0e
Vernonia amygdaline 1000 15.33±0.3b 15.33±0.7 19.33±0.3ab 20.00±1.2b 21.33±0.9a,b 21.0±1.2a,b
780 13.00±0.0c 12.00±0.3c 15.00±0.0c 14.67±0.3c 19.00±2.0a,c 19.00±1.5c
390 12.00±0.0d 12.00±0.0d 12.67±0.3 14.00±0.6d 15.00±0.0d 14.00±0.6d
195 10.00±0.0e 10.00±0.0e 12.00±0.0 11.00±0.0e 13.00±0.0e 13.00±0.0e
Gentamycin 10µ 18.00±0.5a 19.67±0.9a 19.00±0.3a 29.67±0.7a 22.33±1.06a 23.67±0.78a
The values are Mean ± S.E.M (n=3), mean values with different superscript letters differ significantly at P < 0.05, acomparison is between different concentrations of extracts to gentamicin, b,f,g comparison was made among plant extracts only for 1000 mg/ml, c, zcomparison was made among plant extracts only for 780 mg/ml, dcomparison was made among plant extracts only for 390 mg/ml, ecomparison was made among plant extracts only for 195 mg/ml, the negative control has shown no antibacterial activity.
Table 4. The MIC (in mg/ml) of plant extracts against the tested bacteria.
Table 4. The MIC (in mg/ml) of plant extracts against the tested bacteria.
Plants K. pneumonia Salmonella E. coli
Clinical Standard Clinical Standard Clinical Standard
Vernonia Amygdaline 12.18±0.00 12.18±0.00 48.75±0.00 24.38±0.00 6.09±0.00 6.09±0.00
Calpurnia Aurea 12.18±0.00 12.18±0.00 48.75±0.0 48.75±0.0 6.09±0.0 6.09±0.0
Cordia Africana 12.18±0.00 12.18±0.00 48.75±0.00 48.75±0.00 6.09±0.00 6.09±0.00
Croton Macrostachyus 12.18±0.00 12.18±0.00 48.75±0.00 48.75±0.00 6.09±0.00 6.09±0.00
Melia Azedarach 24.38±0.00 24.38±0.00 24.38±0.00 24.38±0.00 12.18±0.00 12.18±0.00
The values are Mean ± S.E.M (n=3).
Table 5. The MBC (in mg/ml) of plant extracts against the tested bacteria.
Table 5. The MBC (in mg/ml) of plant extracts against the tested bacteria.
Plants K. pneumonia Salmonella E. coli
Clinical Standard Clinical Standard Clinical Standard
Vernonia amygdaline 24.38±0.00 24.38±0.00 48.75±0.00 48.75±0.00 12.18±0.00 12.18±0.00
Calpurnia aurea 24.38±0.00 24.38±0.00 97.5±0.00 97.5±0.00 12.18±0.00 12.18±0.00
Cordia africana 24.38±0.00 24.38±0.00 97.5±0.00 97.5±0.00 12.18±0.00 ---
Croton macrostachyus 24.38±0.00 24.38±0.00 97.5±0.00 97.5±0.00 24.38±0.00 24.38±0.00
Melia azedarach 48.75±0.00 48.75±0.00 48.75±0.00 48.75±0.00 24.38±0.00 24.38±0.00
The values are Mean ± S.E.M (n=3), --- = no activity.
Table 6. Phytochemical compositions of the crude extract of leaves of plants.
Table 6. Phytochemical compositions of the crude extract of leaves of plants.
Secondary metabolite tested Tested plants
Calpurnia aurea Cordia africana Croton macrostachyus Melia azedarach Vernonia amygdaline
Flavonoids + + + + +
Alkaloids + _ + + +
Saponins + _- + _- +
Tannins + + _- _- +
Steroid + + + + +
Terpenoids + + + + +
Phenols + _- -_ _- +
Cardiac Glycoides -_ _- _- _- _-
- Absence, + Presence
Table 7. Plant parts and yielded extract using 99.8% concentrated methanol.
Table 7. Plant parts and yielded extract using 99.8% concentrated methanol.
Plant names Part used Amount macerated(g) Yield
(g)
Yield (%) Color of extract
Calpurnia aurea Leaf 100 19.05 11.9 Green
Cordia africana Leaf 100 18.89 11.9 Green
Croton macrostachyus Leaf 100 16.54 7.9 Green
Melia azedarach Leaf 100 18.15 9 Green
Vernonia amygdaline Leaf 100 20.79 10.9 Green
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2025 MDPI (Basel, Switzerland) unless otherwise stated